MS Can Be a Kids’ Disease, Too
0
BY ED TOBIAS IN COLUMNS, THE MS WIRE – A COLUMN BY ED TOBIAS. “The age at which a person is diagnosed with MS is usually between... Read More
Novartis announces FDA approval of Gilenya®
FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis – New approval for Gilenya (fingolimod) addresses a... Read More